JP2022543070A5 - - Google Patents
Info
- Publication number
- JP2022543070A5 JP2022543070A5 JP2022506525A JP2022506525A JP2022543070A5 JP 2022543070 A5 JP2022543070 A5 JP 2022543070A5 JP 2022506525 A JP2022506525 A JP 2022506525A JP 2022506525 A JP2022506525 A JP 2022506525A JP 2022543070 A5 JP2022543070 A5 JP 2022543070A5
- Authority
- JP
- Japan
- Prior art keywords
- nanocage
- fusion protein
- fragment
- ferritin
- monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025154827A JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962881899P | 2019-08-01 | 2019-08-01 | |
| US62/881,899 | 2019-08-01 | ||
| PCT/CA2020/051061 WO2021016724A1 (en) | 2019-08-01 | 2020-07-31 | Multi-valent and multi-specific nanoparticle platforms and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154827A Division JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543070A JP2022543070A (ja) | 2022-10-07 |
| JP2022543070A5 true JP2022543070A5 (cg-RX-API-DMAC7.html) | 2023-08-08 |
Family
ID=74228187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506525A Pending JP2022543070A (ja) | 2019-08-01 | 2020-07-31 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
| JP2025154827A Pending JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154827A Pending JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230145060A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4007779A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022543070A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220107151A (cg-RX-API-DMAC7.html) |
| CN (3) | CN121203033A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020320459A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022001800A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3149320A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022001387A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021016724A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220411508A1 (en) * | 2019-09-09 | 2022-12-29 | The Regents Of The University Of California | Compositions and methods for making and using multispecific antibodies |
| CN117157328A (zh) * | 2021-01-28 | 2023-12-01 | 儿童医院 | Multabody构建体、组合物和方法 |
| EP4370558A4 (en) * | 2021-07-12 | 2025-09-10 | Hospital For Sick Children | OPTIMIZED MULTIBODY CONSTRUCTS, COMPOSITIONS AND METHODS |
| MX2024003140A (es) * | 2021-09-13 | 2024-06-24 | Hospital For Sick Children | Construcciones, composiciones y metodos de multabody optimizados. |
| MX2024003139A (es) * | 2021-09-13 | 2024-06-24 | Hospital For Sick Children | Multabody dirigido a dr5 para el tratamiento del cancer. |
| EP4416189A4 (en) * | 2021-10-16 | 2025-08-27 | Hospital For Sick Children | MODIFIED MULTIBODY CONSTRUCTS, COMPOSITIONS AND METHODS TARGETING SARS-CoV-2 |
| US20250002564A1 (en) * | 2021-10-16 | 2025-01-02 | The Hospital For Sick Children | Modified multabody constructs, compositions, and methods |
| CN116804062A (zh) * | 2022-03-23 | 2023-09-26 | 昆山新蕴达生物科技有限公司 | 一种FcRn结合纳米颗粒及其用途 |
| CN119968382A (zh) * | 2022-09-27 | 2025-05-09 | 科力博株式会社 | 包含主氨基酸由带电和极性氨基酸组成的肽标签并形成自组装体的融合蛋白及使用其纯化重组蛋白的方法 |
| WO2024071970A1 (ko) * | 2022-09-27 | 2024-04-04 | 크리포 주식회사 | 주요 아미노산이 전하성 아미노산으로 구성된 펩타이드 태그를 포함하여 자가 조립체를 형성하는 융합 단백질 및 이를 이용하여 재조합 단백질을 정제하는 방법 |
| KR102946895B1 (ko) * | 2022-10-21 | 2026-04-02 | 충남대학교산학협력단 | SARS-CoV-2 S1 유래 단백질 및 항체 Fc 영역 단백질을 표면에 동시에 디스플레이하는 페리틴 단백질 구조체 및 이의 코로나바이러스 SARS-CoV-2에 대한 백신 용도 |
| WO2024099273A1 (zh) * | 2022-11-07 | 2024-05-16 | 厦门大学 | 一种融合蛋白以及包含其的颗粒化的抗原 |
| EP4634238A1 (en) * | 2022-12-18 | 2025-10-22 | Radiant Biotherapeutics Inc. | Multivalent hematopoietic cell engagers or activators |
| AU2023407259A1 (en) * | 2022-12-18 | 2025-06-26 | Radiant Biotherapeutics Inc. | Multivalent and multispecific cytokine antagonists |
| CN115819626B (zh) * | 2022-12-23 | 2026-04-28 | 北京吉诺卫生物科技有限公司 | 重组铁蛋白纳米颗粒及其制备方法 |
| CN121127490A (zh) * | 2022-12-28 | 2025-12-12 | 生物技术欧洲股份公司 | 靶向hiv的rna组合物 |
| WO2024254514A1 (en) * | 2023-06-08 | 2024-12-12 | The University Of North Carolina At Chapel Hill | Engineered antibody fusion proteins with modulable binding constants and their applications |
| CN116715780A (zh) * | 2023-06-09 | 2023-09-08 | 中国人民解放军陆军军医大学 | 重组铜绿假单胞菌纳米颗粒蛋白及其制备方法和应用 |
| WO2025054730A1 (en) * | 2023-09-13 | 2025-03-20 | The Hospital For Sick Children | Hiv-1-targeted multabody constructs, compositions, and methods |
| WO2026003586A2 (en) * | 2024-06-27 | 2026-01-02 | Popvax Private Limited | Multisubunit herpesvirus vaccines and therapeutics |
| WO2026092903A1 (en) | 2024-10-29 | 2026-05-07 | Albert-Ludwigs-Universität Freiburg Körperschaft Des Öffentlichen Rechts | Encapsulation of dimer or tandem-enzymes within capsid proteins, in particular within engineered encapsulins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7097841B2 (en) * | 2002-05-10 | 2006-08-29 | New Century Pharmaceuticals, Inc. | Ferritin fusion proteins for use in vaccines and other applications |
| KR20160094550A (ko) * | 2015-01-30 | 2016-08-10 | 동국대학교 산학협력단 | 단일사슬항체조각과 페리틴을 포함하는 융합단백질 및 그의 용도 |
| CA3071922A1 (en) * | 2017-08-04 | 2019-02-07 | The Governing Council Of The University Of Toronto | Nanoparticle platform for antibody and vaccine delivery |
-
2020
- 2020-07-31 CA CA3149320A patent/CA3149320A1/en active Pending
- 2020-07-31 EP EP20847401.5A patent/EP4007779A4/en active Pending
- 2020-07-31 CN CN202511333627.3A patent/CN121203033A/zh active Pending
- 2020-07-31 MX MX2022001387A patent/MX2022001387A/es unknown
- 2020-07-31 AU AU2020320459A patent/AU2020320459A1/en active Pending
- 2020-07-31 US US17/631,588 patent/US20230145060A1/en active Pending
- 2020-07-31 CN CN202511333631.XA patent/CN121449754A/zh active Pending
- 2020-07-31 CN CN202080069559.3A patent/CN114867754A/zh active Pending
- 2020-07-31 WO PCT/CA2020/051061 patent/WO2021016724A1/en not_active Ceased
- 2020-07-31 KR KR1020227005980A patent/KR20220107151A/ko active Pending
- 2020-07-31 JP JP2022506525A patent/JP2022543070A/ja active Pending
- 2020-07-31 BR BR112022001800A patent/BR112022001800A2/pt unknown
-
2025
- 2025-09-18 JP JP2025154827A patent/JP2026004351A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20030198956A1 (en) | Staged assembly of nanostructures | |
| US20040018587A1 (en) | Nanostructures containing antibody assembly units | |
| CN114867754A (zh) | 多价和多特异性纳米颗粒平台和方法 | |
| JP2023504914A5 (cg-RX-API-DMAC7.html) | ||
| CN112409480B (zh) | 结合血清白蛋白的蛋白及其用途 | |
| US20230190910A1 (en) | Scaffolded hiv-1 vaccine immunogens | |
| JP2024504777A (ja) | Multabody構築物、組成物および方法 | |
| JP2023553697A5 (cg-RX-API-DMAC7.html) | ||
| US20250263469A1 (en) | Polypeptides targeting sars-cov-2 and related compositions and methods | |
| JP2026004299A5 (cg-RX-API-DMAC7.html) | ||
| JP2023544211A5 (cg-RX-API-DMAC7.html) | ||
| US20250197481A1 (en) | Antigen Binding Polypeptides, Antigen Binding Polypeptide Complexes and Methods of Use Thereof in HIV | |
| EP3207064A1 (en) | Methods and compostions involving protein g variants | |
| RU2562165C2 (ru) | Альфатела для ингибирования проникновения вич | |
| CN116496389A (zh) | 用于治疗hbv感染及相关疾病的表位肽及抗体 | |
| TW201118205A (en) | Phage displaying system expressing single chain antibody | |
| US20250011397A1 (en) | Modified multabody constructs, compositions, and methods targeting sars-cov-2 | |
| US20250002564A1 (en) | Modified multabody constructs, compositions, and methods | |
| RU2022103853A (ru) | Мультивалентные и мультиспецифические платформы наночастиц и способы | |
| AU2003290260A1 (en) | Peptide oligomers for use as HIV vaccines | |
| CN116615255A (zh) | 靶向SARS-CoV-2的多肽及相关组合物和方法 | |
| WO2025054730A1 (en) | Hiv-1-targeted multabody constructs, compositions, and methods | |
| Wu | Molecular biorecognition of coiled-coil motifs in the construction of hybrid hydrogels and drug-free macromolecular therapeutics | |
| Konrad | Development of a covalent site-specific antibody labeling strategy by the use of photoactivable Z domains |